Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of reteplase thrombolysis for acute pulmonary embolism
CTR20191034Phase 2Active
- Sponsor
- China Resources Angde Biopharmaceutical
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of reteplase in pulmonary embolism (PE), sponsored by China Resources Angde Biopharmaceutical. Started Apr 2020; status: active.
02
Drugs
reteplase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on CTR20191034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191034.